Selected research
Industry Research
Efavirenz Tablets Industry Research Report 2026
Market perspective
The global Efavirenz Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Efavirenz Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Efavirenz Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Efavirenz Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Efavirenz Tablets include Aurobindo Pharma, Cipla, Hetero, Strides Pharma, Anhui Biochem Bio-Pharmaceutical, Huahai Pharmaceutical and DESANO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Efavirenz Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Efavirenz Tablets Market by Company
Aurobindo Pharma
Cipla
Hetero
Strides Pharma
Anhui Biochem Bio-Pharmaceutical
Huahai Pharmaceutical
DESANO
Efavirenz Tablets Segment by Type
200mg
50mg
600mg
Efavirenz Tablets Segment by Application
Adult
Child
Efavirenz Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Efavirenz Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Efavirenz Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Efavirenz Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Efavirenz Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Efavirenz Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Efavirenz Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 200mg
- 50mg
- 600mg
Applications
- Adult
- Child
Companies covered
- Aurobindo Pharma
- Cipla
- Hetero
- Strides Pharma
- Anhui Biochem Bio-Pharmaceutical
- Huahai Pharmaceutical
- DESANO
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Efavirenz Tablets Market Size (2021-2032)
- 2.2.2 Global Efavirenz Tablets Sales (2021-2032)
- 2.2.3 Global Efavirenz Tablets Market Average Price (2021-2032)
- 2.3 Efavirenz Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 200mg
- 2.3.3 50mg
- 2.3.4 600mg
- 2.4 Efavirenz Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Adult
- 2.4.3 Child
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Efavirenz Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Efavirenz Tablets Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Efavirenz Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Efavirenz Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Efavirenz Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Efavirenz Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Efavirenz Tablets, Product Type & Application
- 3.8 Global Manufacturers of Efavirenz Tablets, Established Date
- 3.9 Global Efavirenz Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Aurobindo Pharma
- 4.1.1 Aurobindo Pharma Company Information
- 4.1.2 Aurobindo Pharma Business Overview
- 4.1.3 Aurobindo Pharma Efavirenz Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Aurobindo Pharma Efavirenz Tablets Product Portfolio
- 4.1.5 Aurobindo Pharma Recent Developments
- 4.2 Cipla
- 4.2.1 Cipla Company Information
- 4.2.2 Cipla Business Overview
- 4.2.3 Cipla Efavirenz Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Cipla Efavirenz Tablets Product Portfolio
- 4.2.5 Cipla Recent Developments
- 4.3 Hetero
- 4.3.1 Hetero Company Information
- 4.3.2 Hetero Business Overview
- 4.3.3 Hetero Efavirenz Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hetero Efavirenz Tablets Product Portfolio
- 4.3.5 Hetero Recent Developments
- 4.4 Strides Pharma
- 4.4.1 Strides Pharma Company Information
- 4.4.2 Strides Pharma Business Overview
- 4.4.3 Strides Pharma Efavirenz Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Strides Pharma Efavirenz Tablets Product Portfolio
- 4.4.5 Strides Pharma Recent Developments
- 4.5 Anhui Biochem Bio-Pharmaceutical
- 4.5.1 Anhui Biochem Bio-Pharmaceutical Company Information
- 4.5.2 Anhui Biochem Bio-Pharmaceutical Business Overview
- 4.5.3 Anhui Biochem Bio-Pharmaceutical Efavirenz Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Anhui Biochem Bio-Pharmaceutical Efavirenz Tablets Product Portfolio
- 4.5.5 Anhui Biochem Bio-Pharmaceutical Recent Developments
- 4.6 Huahai Pharmaceutical
- 4.6.1 Huahai Pharmaceutical Company Information
- 4.6.2 Huahai Pharmaceutical Business Overview
- 4.6.3 Huahai Pharmaceutical Efavirenz Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Huahai Pharmaceutical Efavirenz Tablets Product Portfolio
- 4.6.5 Huahai Pharmaceutical Recent Developments
- 4.7 DESANO
- 4.7.1 DESANO Company Information
- 4.7.2 DESANO Business Overview
- 4.7.3 DESANO Efavirenz Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 DESANO Efavirenz Tablets Product Portfolio
- 4.7.5 DESANO Recent Developments
5 Global Efavirenz Tablets Market Scenario by Region
- 5.1 Global Efavirenz Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Efavirenz Tablets Sales by Region: 2021-2032
- 5.2.1 Global Efavirenz Tablets Sales by Region: 2021-2026
- 5.2.2 Global Efavirenz Tablets Sales by Region: 2027-2032
- 5.3 Global Efavirenz Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Efavirenz Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Efavirenz Tablets Revenue by Region: 2027-2032
- 5.4 North America Efavirenz Tablets Market Facts & Figures by Country
- 5.4.1 North America Efavirenz Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Efavirenz Tablets Sales by Country (2021-2032)
- 5.4.3 North America Efavirenz Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Efavirenz Tablets Market Facts & Figures by Country
- 5.5.1 Europe Efavirenz Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Efavirenz Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Efavirenz Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Efavirenz Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Efavirenz Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Efavirenz Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Efavirenz Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Efavirenz Tablets Market Facts & Figures by Country
- 5.7.1 South America Efavirenz Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Efavirenz Tablets Sales by Country (2021-2032)
- 5.7.3 South America Efavirenz Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Efavirenz Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Efavirenz Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Efavirenz Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Efavirenz Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Efavirenz Tablets Sales by Type (2021-2032)
- 6.1.1 Global Efavirenz Tablets Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Efavirenz Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Efavirenz Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Efavirenz Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Efavirenz Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Efavirenz Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Efavirenz Tablets Sales by Application (2021-2032)
- 7.1.1 Global Efavirenz Tablets Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Efavirenz Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Efavirenz Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Efavirenz Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Efavirenz Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Efavirenz Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Efavirenz Tablets Value Chain Analysis
- 8.1.1 Efavirenz Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Efavirenz Tablets Production Mode & Process
- 8.2 Efavirenz Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Efavirenz Tablets Distributors
- 8.2.3 Efavirenz Tablets Customers
9 Global Efavirenz Tablets Analyzing Market Dynamics
- 9.1 Efavirenz Tablets Industry Trends
- 9.2 Efavirenz Tablets Industry Drivers
- 9.3 Efavirenz Tablets Industry Opportunities and Challenges
- 9.4 Efavirenz Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst